75 STATE STREET, BOSTON, MA
Election of Directors - Michael Landsittel and Cameron Turtle Elected
CFO Departure - Lori Firmani Steps Down at Damora Therapeutics
Damora Therapeutics Dismisses EY Denmark as Independent Auditor
Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
Earnings Release
Underwriting Agreement with Jefferies and Leerink for $295.9M Offering
Departure of CEO Hans T. Schambye Effective February 10, 2026
Investor Presentation
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Amended Notice of Proposed Sale of Securities
Submission Upload
Correspondence